TRANSWELL BIOTECH CO LTD has a total of 23 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2016. It filed its patents most often in United States, Canada and China. Its main competitors in its focus markets pharmaceuticals, biotechnology and basic materials chemistry are ZHAOQING DAHUANONG BIOLOGY MEDICINE CO LTD, PHICO THERAPEUTICS LTD and GAMIDA CELL LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | Canada | 3 | |
#3 | China | 3 | |
#4 | EPO (European Patent Office) | 3 | |
#5 | Republic of Korea | 3 | |
#6 | Taiwan | 3 | |
#7 | WIPO (World Intellectual Property Organization) | 3 | |
#8 | Argentina | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Basic materials chemistry | |
#4 | Medical technology |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Preservation of human bodies | |
#3 | Syringes | |
#4 | Therapeutic chemical compounds | |
#5 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Lin Cheng-Yi | 10 |
#2 | Wu Taijung | 8 |
#3 | Lee Catherine | 8 |
#4 | She Bin-Ru | 5 |
#5 | Chao Chih-Yuan | 5 |
#6 | Huang Ting-Yu | 5 |
#7 | Chang Ya-Hsuan | 5 |
#8 | Chiang Kun-Chi | 5 |
#9 | Lin Cheng Yi | 4 |
#10 | Chiang Kun Chi | 2 |
Publication | Filing date | Title |
---|---|---|
US2018094235A1 | Compositions and methods for maintaining cell viability | |
TW201813634A | Pramipexole transdermal delivery system and uses thereof | |
KR20190065184A | Pramipexol transdermal delivery system and its use |